Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRAKLatar belakang Akurasi triple diagnostic USG guided FNAB untuk menentukan keganasan pada kasus nodul tirodi masih belum diketahui. Hal tersebut penting untuk diketahui sehingga tindakan definitif dan jenis operasi dapat ditentukan tanpa harus dilakukan pemeriksaan potong beku.Metode Penelitian dilakukan pada 131 pasien dengan pembesaran kelenjar tiroid pada periode Januari 2014 ndash; Desember 2014 dengan menggunakan desain potong lintang. Penelitian ini menghitung nilai sensitivitas, spesifisitas, nilai prediksi positif, nilai prediksi negatif, akurasi triple diagnostic dengan USG guided FNAB dibandingkan dengan histopatologi.Hasil Hasil penelitian ini menunjukan triple diagnostic yang concordant ganas memiliki sensitivitas 81,17 , spesifisitas 96,55 , nilai prediksi positif 98,57 , nilai prediksi negatif 36,36 , dan akurasi 85,08 .Kesimpulan Tingginya nilai prediksi positif yang didapatkan dalam penelitian ini, sehingga triple diagnostic dapat digunakan untuk terapi definitif tanpa dilakukan pemeriksaan potong beku intra operatif.

---

ABSTRACT Background The triple diagnostic accuracy with Ultrasound guided FNAB to determine the risk of malignancy in cases of thyroid nodules remains unknown. It is important to know so that definitive measures and types of operations can be determined without the need for a frozen section. Methods The study was conducted using cross sectional design on 131 patients with thyroid nodule in the period of January 2014 December 2014. This study calculated the values of sensitivity, specificity, positive predictive value, negative predictive value, triple diagnostic accuracy with ultrasound guided FNAB compared with histopathological result.Results This study show triple diagnostic with malignant concordant has sensitivity of 81.17 , specificity of 96.55 , positive predictive value of 98.57 , negative predictive value of36.36 , and 85.08 accuracy.Conclusions The high positive predictive values obtained in this study, show that triple diagnostic can be used for definitive therapy without intraoperative frozen section"

"Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. "